Home >> General Pharmaceuticals >> Housing >> Food & Beverage >>

MediWound Ltd. - Product Pipeline Review - 2014

Published: Dec-2014 | Format: PDF | Global Markets Direct | Number of pages: 20 | Code: MRS - 18609

Global Markets Directs, MediWound Ltd. Product Pipeline Review 2014, provides an overview of the MediWound Ltd.s pharmaceutical research and development focus.

This report provides comprehensive information on the current therapeutic developmental pipeline of MediWound Ltd.s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.

Global Markets Directs report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Directs proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Directs team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.


The report provides brief overview of MediWound Ltd. including business description, key information and facts, and its locations and subsidiaries
The report reviews current pipeline of MediWound Ltd.s human therapeutic division and enlists all their major and minor projects
The report features product description and descriptive mechanism of action for key pipeline products along with the products developmental history and major milestones
Special feature on out-licensed and partnered product portfolio
The report summarizes all the dormant and discontinued pipeline projects
Latest company statement
Latest news and deals relating to the MediWound Ltd.s pipeline products

Reasons to buy

Evaluate MediWound Ltd.s strategic position with total access to detailed information on its product pipeline
Assess the growth potential of MediWound Ltd. in its therapy areas of focus
Identify new drug targets and therapeutic classes in the MediWound Ltd.s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas
Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps
Develop strategic initiatives by understanding the focus areas of MediWound Ltd. and exploit collaboration and partnership opportunities
Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
Plan mergers and acquisitions effectively by identifying the most promising pipeline of MediWound Ltd.
Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
Explore the dormant and discontinued projects of MediWound Ltd. and identify potential opportunities in those areas
Avoid Intellectual Property Rights related issues

Table Of Content

Table of Contents 2
List of Tables 3
List of Figures 3
MediWound Ltd. Snapshot 4
MediWound Ltd. Overview 4
Key Information 4
Key Facts 4
MediWound Ltd.- Research and Development Overview 5
Key Therapeutic Areas 5
MediWound Ltd.- Pipeline Review 7
Pipeline Products by Stage of Development 7
Pipeline Products- Monotherapy 8
MediWound Ltd.- Pipeline Products Glance 9
MediWound Ltd.- Late Stage Pipeline Products 9
Phase III Products/Combination Treatment Modalities 9
MediWound Ltd.- Clinical Stage Pipeline Products 10
Phase II Products/Combination Treatment Modalities 10
MediWound Ltd.- Early Stage Pipeline Products 11
Preclinical Products/Combination Treatment Modalities 11
MediWound Ltd.- Drug Profiles 12
bromelains 12
Product Description 12
Mechanism of Action 12
R&D Progress 12
EscharEx 13
Product Description 13
Mechanism of Action 13
R&D Progress 13
MWPC-003 14
Product Description 14
Mechanism of Action 14
R&D Progress 14
MediWound Ltd.- Pipeline Analysis 15
MediWound Ltd.- Pipeline Products by Route of Administration 15
MediWound Ltd.- Pipeline Products by Molecule Type 16
MediWound Ltd.- Recent Pipeline Updates 17
MediWound Ltd.- Locations And Subsidiaries 18
Head Office 18

Appendix 19
Methodology 19
Coverage 19
Secondary Research 19
Primary Research 19
Expert Panel Validation 19
Contact Us 20
Disclaimer 20

List of Tables

MediWound Ltd., Key Information 4
MediWound Ltd., Key Facts 4
MediWound Ltd.- Pipeline by Indication, 2014 6
MediWound Ltd.- Pipeline by Stage of Development, 2014 7
MediWound Ltd.- Monotherapy Products in Pipeline, 2014 8
MediWound Ltd.- Phase III, 2014 9
MediWound Ltd.- Phase II, 2014 10
MediWound Ltd.- Preclinical, 2014 11
MediWound Ltd.- Pipeline by Route of Administration, 2014 15
MediWound Ltd.- Pipeline by Molecule Type, 2014 16
MediWound Ltd.- Recent Pipeline Updates, 2014 17

List of Figures

MediWound Ltd. - Pipeline by Top 10 Indication, 2014 6
MediWound Ltd. - Pipeline by Stage of Development, 2014 7
MediWound Ltd. - Monotherapy Products in Pipeline, 2014 8
MediWound Ltd. - Pipeline by Top 10 Route of Administration, 2014 15
MediWound Ltd. - Pipeline by Top 10 Molecule Type, 2014 16

Inquiry For Buying

Please fill your details below, to inquire about this report:
Indicates required fields

Request Sample

Please fill your details below, to receive sample report:
Indicates required fields

  • Payment Mode

COVID-19 Pandemic Impacts

Our Analysts and Consultants are working ceaselessly to congregate, identify, analyze, and portray the Actual Impacts of COVID-19 Global Pandemic in each of our published as well as ongoing research reports to Redefine and Revise Current and Future Market Trends, Growth Rates, And Market Size Projections across the Globe as well as in different Regions and individual Countries.

Single User | $(USD)1500 View Pricing